Skip to main content

Children Services

 Nusinersen for treating children and young people up to 17 years old with spinal muscular atrophy, Policy Position Statement (PPS191), August 2025.pdf (PDF, 485Kb)
 Paediatric Endocrinology, Service Specification (SS163), June 2024 (PDF, 512Kb)
 Paediatric Nephrology, Service Specification (SS169), August 2025.pdf (PDF, 595Kb)
 Paediatric Neuropsychology, Service Specification (SS296), March 2025.pdf (PDF, 530Kb)
 Paediatric Persistent Pain Service for children aged up to 16 years, Commissioning Policy (CP290), January 2025.pdf (PDF, 898Kb)
 Paediatric Persistent Pain Service for children aged up to 16 years, Service Specification (SS290), January 2025.pdf (PDF, 1.1Mb)
 Risdiplam for Spinal Muscular Atrophy for people aged under 16 years, Policy Position Statement (PP240). May 2022.pdf (PDF, 361Kb)
 Selective Dorsal Rhizotomy (SDR) for the treatment of spasticity in cerebral palsy in children aged 3-9 years, Policy Position Statement (PP245), March 2024.pdf (PDF, 975Kb)
 Selpercatinib for advanced thyroid cancer with RET alterations after treatment with a targeted cancer drug in people 12 years and over, Policy Position Statement 9PPS321), April 2026 (PDF, 403Kb)
 Setmelanotide for treating obesity and hyperphagia in Bardet-Biedl syndrome in people 6-17 years of age, Policy Position Statement (PPS298), April 2025.pdf (PDF, 406Kb)
 Specialised Fetal Medicine, Commissioning Policy (CP97), October 2023.pdf (PDF, 372Kb)
 Specialised Paediatric Gastroenterology, Hepatology and Nutrition (PGHAN) (CP211) May 2023.pdf (PDF, 759Kb)
 Specialised Paediatric Neurological Rehabilitation, Commissioning Policy (CP160), April 2018.pdf (PDF, 385Kb)
 Specialised Paediatric Neurology, Service Specification (SS213), June 2024.pdf (PDF, 492Kb)
 Specialised Paediatric Orthopaedic Surgery, Service Specification (SS230), March 2025.pdf (PDF, 517Kb)
 Specialised Paediatric Rheumatology Service, Service Specification (SS172), April 2026.pdf (PDF, 587Kb)
 Specialist Paediatric Imaging Service (excluding neuroimaging) (aged up to 16 years), Service Specification (SS161), February 2025.pdf (PDF, 570Kb)
 Tofacitinib for treating juvenile idiopathic arthritis in people from 2 years old up to their 16th birthday, Policy Position Statement (PP229), May 2022.pdf (PDF, 311Kb)